Aelbrecht-Meurisse Capucine, Ryckewaert Thomas, Pannier Diane, Gamblin Vincent, Garcia Vincent, Aelbrecht Stéphane, Penel Nicolas
Centre Oscar Lambret, département d'oncologie médicale, 3, rue Frédéric Combemale, 59000 Lille, France.
Centre Oscar Lambret, département d'oncologie médicale, 3, rue Frédéric Combemale, 59000 Lille, France.
Bull Cancer. 2021 Apr;108(4):415-423. doi: 10.1016/j.bulcan.2020.11.020. Epub 2021 Mar 4.
The management of oncology patients, especially hospitalized patients, can lead to almost daily discussions regarding therapeutic limitations. Here, we review the history and propose a summary of the texts framing the notion of "withholding and withdrawing life-sustaining treatment" in oncology practice in France. This decision is regulated by the Claeys-Léonetti Law of February 2, 2016 recommending a collegial discussion and its documentation in the medical record. The decision to withhold or withdraw life-sustaining treatments is the subject of discussion between the patient, his physicians and his family and may take place at any time during his management. The work of intensive-care physicians provides many useful recommendations for acute oncology situations, however articles specific for oncology practice are scarce; this is a topic that oncologists must take up.
肿瘤患者的管理，尤其是住院患者的管理，几乎每天都会引发关于治疗局限性的讨论。在此，我们回顾相关历史，并对法国肿瘤学实践中构成“ withholding and withdrawing life - sustaining treatment”概念的文本进行总结。这一决定受2016年2月2日的《克莱伊斯 - 莱奥内蒂法》监管，该法建议进行合议讨论并将其记录在病历中。停止或撤销维持生命治疗的决定是患者、其医生和家属之间讨论的主题，并且可能在其治疗过程中的任何时候做出。重症监护医生的工作为急性肿瘤情况提供了许多有用的建议，然而针对肿瘤学实践的具体文章却很少；这是肿瘤学家必须关注的一个话题。
